Skip to content

    Pediatrix Medical Group (MD) stock price & financials

    View MD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+54.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $511.16M
    $502.36M
    $458.36M
    $468.84M
    $492.88M
    -3.6%
    $493.77M
    -1.7%
    $476.20M
    +3.9%
    $487.78M
    +4.0%
    Stable
    Operating Profit
    $33.83M
    $39.29M
    $32.10M
    $59.87M
    $68.05M
    +101.2%
    $48.79M
    +24.2%
    $41.66M
    +29.8%
    $56.92M
    -4.9%
    Strengthening
    Net Profit
    $19.44M
    $30.48M
    $20.74M
    $39.26M
    $71.71M
    +268.8%
    $33.68M
    +10.5%
    $29.57M
    +42.6%
    $39.84M
    +1.5%
    Strengthening
    EPS
    $0.23
    $0.25
    $0.46
    $0.85
    +269.6%
    $0.37
    +48.0%
    $0.50
    +8.7%
    Strengthening
    Other Income
    -$8.59M
    -$5.96M
    -$4.01M
    -$4.90M
    $19.73M
    -$3.20M
    +46.4%
    -$2.81M
    +29.9%
    -$2.92M
    +40.3%
    Strengthening
    Interest
    $10.13M
    $9.71M
    $9.15M
    $9.13M
    $8.94M
    -11.7%
    $8.74M
    -10.0%
    $8.27M
    -9.7%
    $8.17M
    -10.5%
    Weakening
    Depreciation
    Profit before Tax
    $25.23M
    $33.33M
    $28.09M
    $54.97M
    $87.78M
    +247.8%
    $45.59M
    +36.8%
    $38.84M
    +38.3%
    $54.00M
    -1.8%
    Strengthening
    MarginsOPM
    6.6%
    7.8%
    7.0%
    12.8%
    13.8%
    +108.6%
    9.9%
    +26.3%
    8.8%
    +25.0%
    11.7%
    -8.6%
    Strengthening
    Tax
    23.0%
    8.6%
    26.2%
    28.6%
    18.3%
    -20.3%
    26.1%
    +205.6%
    23.9%
    -8.8%
    26.2%
    -8.3%
    Strengthening
    ReturnsROIC
    -150.4%
    -235.8%
    -160.4%
    -303.8%
    -554.8%
    -268.8%
    -260.6%
    -10.5%
    -228.8%
    -42.6%
    -308.3%
    -1.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$40.77M$107.87M$1.12B$387.39M$9.82M$73.26M$229.94M$375.24M$288.88M
    Short-Term Investments
    Total Current Assets$659.98M$731.51M$1.55B$840.56M$427.99M$483.45M$639.61M$763.51M$660.14M
    Net PP&E$90.43M$129.09M$121.12M$121.44M$129.09M$137.33M$73.26M$70.31M$38.70M
    Goodwill$4.06B$1.48B$1.48B$1.51B$1.53B$1.38B$1.24B$1.26B$1.27B
    Intangibles$313.17M$28.59M$26.64M$21.57M$18.49M$21.24M$11.60M$16.86M$14.51M
    Total Assets$5.94B$4.15B$3.35B$2.72B$2.35B$2.22B$2.15B$2.25B$2.13B
    LiabilitiesTotal Current Liabilities$502.76M$541.82M$444.33M$427.37M$426.98M$388.95M$434.11M$458.91M$501.58M
    Short-Term Debt
    Long-Term Debt$1.97B$1.70B$1.70B$989.70M$637.20M$622.20M$611.20M
    Long-Term Leases$0$44.64M$40.97M$41.40M$44.21M$47.24M$31.95M$25.69M$23.48M
    Total Liabilities$2.85B$2.65B$2.60B$1.83B$1.46B$1.37B$1.39B$1.38B$1.25B
    EquityCommon Stock & APIC$878.0K$842.0K$856.0K$864.0K$829.0K$840.0K$859.0K$830.0K$812.0K
    Retained Earnings$2.09B$510.13M-$286.35M-$155.39M-$89.06M-$149.47M-$248.54M-$83.15M-$13.74M
    Total Equity$3.09B$1.50B$747.49M$896.49M$891.63M$849.06M$764.94M$865.85M$880.98M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$313.71M$357.71M$204.62M$76.74M$166.94M$137.32M$206.57M$271.09M$246.86M
    Cash from Investing-$142.77M$102.45M$815.51M-$53.07M-$56.95M-$48.18M-$35.41M-$18.30M-$9.64M
    Cash from Financing-$170.61M-$393.07M-$4.16M-$760.12M-$487.55M-$25.71M-$14.48M-$107.49M-$173.08M
    SummaryCapital Expenditure-$17.12M-$19.27M-$28.79M-$32.25M-$29.71M-$33.33M-$22.02M-$18.46M-$18.25M
    Free Cash Flow$296.59M$338.44M$175.83M$44.49M$137.23M$104.00M$184.55M$252.63M$228.61M
    FCF Margin17.2%19.0%10.1%2.3%7.0%5.2%9.2%13.2%11.7%

    Ratios